HealthQuill Health
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according to a WHO report.
Drugs Health Medical

Novel mRNA vaccine shows promise in treating aggressive brain cancer

HQ Team May 3, 2024: A vaccine using the mRNA technique combined with personalised delivery of tumor cells has been developed to combat.

Read More
According to a 2022 survey, 20% of Indians resigned and 29% took leave from their firms due to mental health problems. This means that around a quarter of the country’s workforce is unable to be available for their professional demands.
Drugs Health Medical Opinion

Opinion: Mental health rules at office may change ‘worry ship’ concerns

Aparna S May 3, 2024: Employees’ mental health is increasingly recognised as an indicator of the work culture and employer-employee relationship. Poor mental.

Read More
Novartis AG will buy a US-based biotechnology company Mariana Oncology to expand its cancer portfolio for $1 billion.
Drugs Health Pharma

Novartis AG to buy Mariana Oncology for $1 billion to build RLT assets

HQ Team May 2, 2024: Novartis AG will buy a US-based biotechnology company Mariana Oncology to expand its cancer portfolio for $1 billion..

Read More
Exposure to nitrogen dioxide, which comes mainly from traffic emissions, may affect brain development in children between four and eight years, a study finds.
Climate Health Pharma

Traffic emissions may lower children’s attention capacity in 4-8 year group

HQ Team May 2, 2024: Exposure to nitrogen dioxide, which comes mainly from traffic emissions, may affect brain development in children between four.

Read More
Novo Nordisk, Europe’s most valuable company, has raised its 2024 revenue outlook on the back of its popular weight-loss drug Wegovy, as it announced its January to March operating profit rose 27% to Danish kroner 31.8 billion.
Drugs Health Pharma

Novo Nordisk raises sales forecast on strong demand for anti-obesity drug

HQ Team May 2, 2024: Novo Nordisk, Europe’s most valuable company, has raised its 2024 revenue outlook on the back of its popular.

Read More
The Food and Drug Administration has cleared X4 Pharmaceutical’s drug to treat a rare genetic disease that occurs in one in five million births.
Drugs Health Pharma

X4 Pharmaceutical’s drug to fight WHIM syndrome gets green light

HQ Team April 30, 2024: The Food and Drug Administration has cleared X4 Pharmaceutical’s drug to treat a rare genetic disease that occurs.

Read More
El Niño climate decimates farming in southern Africa, UN official says
Climate Health Pharma

El Niño climate decimates farming in southern Africa, UN official says

HQ Team April 30, 2024: El Niño climate phase, which started last year, has caused ocean temperatures to rise and has already “decimated”.

Read More
the BCG vaccine does not provide consistent and optimal protection against TB there is an urgent need for a more effective vaccine.
Drugs Health Opinion Pharma

Opinion: Time to explore a new vaccine, booster for tuberculosis

By K Leelamoni April 30, 2024: Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent — next to.

Read More
The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond the chemotherapy stage.
Drugs Health Pharma

Pfizer gets full US regulatory approval for cervical cancer drug

HQ Team April 30, 2024: The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond.

Read More
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.
Drugs Health Medical

High alcohol intake linked to elevated risk of developing peripheral artery disease

HQ Team April 27, 2024: A study by the Karolinska Institutet, Stockholm, has found a link between alcohol consumption and Peripheral artery disease.

Read More